Table 5. Stratified analyses between PD-1 rs10204525 T>C polymorphism and EGJA risk by sex, age, smoking status and alcohol consumption.
Variable | PD-1 rs10204525 T>C (case/control) a | Adjusted OR b (95% CI); P | ||||||
---|---|---|---|---|---|---|---|---|
TT | TC | CC | TT | TC | CC | TC / CC | CC vs. (TC/TT) | |
Sex | ||||||||
Male | 384/621 | 289/476 | 71/94 | 1.00 | 0.96 (0.79–1.17); P: 0.704 |
1.20 (0.86–1.67); P: 0.294 |
1.04 (0.86–1.25); P: 0.700 |
1.24(0.90–1.72); P: 0.194 |
Female | 160/249 | 108/196 | 27/38 | 1.00 | 0.79(0.58–1.08); P: 0.140 |
1.08 (0.63–1.85); P: 0.776 |
0.89(0.66–1.19); P: 0.422 |
1.23 (0.73–2.08); P: 0.433 |
Age | ||||||||
<64 | 245/442 | 187/310 | 50/71 | 1.00 | 1.04 (0.82–1.33); P: 0.725 |
1.26 (0.85–1.87); P: 0.260 |
1.13(0.90–1.42); P: 0.283 |
1.27 (0.86–1.86); P: 0.226 |
≥64 | 299/428 | 210/362 | 48/61 | 1.00 | 0.80 (0.64–1.01); P: 0.055 |
1.10 (0.73–1.66); P: 0.640 |
0.88 (0.71–1.09); P: 0.237 |
1.24 (0.83–1.84); P: 0.291 |
Smoking status | ||||||||
Never | 385/679 | 300/534 | 68/108 | 1.00 | 0.94(0.78–1.13); P: 0.505 |
1.08(0.78–1.50); P: 0.644 |
1.01 (0.84–1.21); P: 0.926 |
1.14 (0.83–1.57); P: 0.419 |
Ever | 159/191 | 97/138 | 30/24 | 1.00 | 0.84 (0.60–1.18); P: 0.321 |
1.60 (0.89–2.88); P: 0.115 |
0.97 (0.71–1.33); P: 0.849 |
1.74 (0.98–3.08); P: 0.058 |
Alcohol consumption | ||||||||
Never | 464/774 | 339/610 | 83/121 | 1.00 | 0.89(0.74–1.05); P: 0.171 |
1.11 (0.82–1.50); P: 0.508 |
0.96 (0.82–1.14); P: 0.660 |
1.20(0.89–1.61); P: 0.230 |
Ever | 80/96 | 58/62 | 15/11 | 1.00 | 1.11 (0.68–1.79); P: 0.680 |
2.22(0.91–5.43); P: 0.080 |
1.26 (0.80–1.99); P: 0.328 |
2.14 (0.89–5.10); P: 0.088 |
aThe genotyping was successful in 1063 (97.74%) EGJA cases, and 1677 (99.82%) controls for PD-1 rs10204525 T>C;
bAdjusted for age, sex, smoking status and alcohol consumption (besides stratified factors accordingly) in a logistic regression model.